CervoMed Inc. Business Acquisition, Pro Forma Net Income (Loss)
CervoMed Inc. (CRVO) reported Business Acquisition, Pro Forma Net Income (Loss) of -$13.29 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-04-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2015-04-03
- CervoMed Inc. business acquisition, pro forma net income (loss) for the quarter ending 2014-12-31 was -$3.63M, a 517.89% decline year-over-year.
- CervoMed Inc. business acquisition, pro forma net income (loss) for the quarter ending 2014-09-30 was -$3.45M.
- CervoMed Inc. business acquisition, pro forma net income (loss) for the quarter ending 2014-06-30 was -$4.46M, a 365.73% decline year-over-year.
- CervoMed Inc. business acquisition, pro forma net income (loss) for the quarter ending 2014-03-31 was -$1.75M.
- CervoMed Inc. business acquisition, pro forma net income (loss) for fiscal 2014 was -$13.29M.
- CervoMed Inc. business acquisition, pro forma net income (loss) for fiscal 2013 was -$2.86M.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month |
|---|---|---|---|---|
| 2014-12-31 | -$3.63M derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-03 | -$7.08M derived: sum of 2 quarters · filed 2015-04-03 | -$11.54M derived: sum of 3 quarters · filed 2015-04-03 | -$13.29M 10-K · filed 2015-04-03 |
| 2014-09-30 | -$3.45M 10-Q · filed 2014-11-12 | -$7.90M derived: sum of 2 quarters · filed 2014-11-12 | -$9.65M 10-Q · filed 2014-11-12 | -$8.78M derived: sum of 4 quarters · filed 2015-04-03 |
| 2014-06-30 | -$4.46M 10-Q · filed 2014-08-14 | -$6.07M 10-Q · filed 2014-08-14 | -$5.33M derived: sum of 3 quarters · filed 2015-04-03 | -$7.83M derived: sum of 4 quarters · filed 2015-04-03 |
| 2014-03-31 | -$1.75M derived: 10-K 12 month − 3 quarters · filed 2015-04-03 | -$878.63K derived: sum of 2 quarters · filed 2015-04-03 | -$3.38M derived: sum of 3 quarters · filed 2015-04-03 | -$1.70M derived: sum of 4 quarters · filed 2015-04-03 |
| 2013-12-31 | $869.33K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-03 | -$1.63M derived: sum of 2 quarters · filed 2015-04-03 | $47.21K derived: sum of 3 quarters · filed 2015-04-03 | -$2.86M 10-K · filed 2015-04-03 |
| 2013-09-30 | -$2.50M 10-Q · filed 2014-11-12 | -$822.12K derived: sum of 2 quarters · filed 2014-11-12 | -$3.73M 10-Q · filed 2014-11-12 | |
| 2013-06-30 | $1.68M 10-Q · filed 2014-08-14 | -$1.32M 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |